A proposal in the Nevada Assembly is seeking establish a psychedelics therapy pilot program for patients with certain mental health conditions, Marijuana Moment reports. Assemblymember Max Carter (D) filed the bill on Monday with 18 cosponsors after participating in a psychedelics policy summit in February hosted by the Nevada Coalition for Psychedelic Medicines.
The proposal, AB378, would task the state Department of Health and Human Services with administering an Alternative Therapy Pilot Program authorizing the medicinal use of psilocybin, psilocin, DMT, ibogaine, and mescaline. Psychedelic treatments would be available for a wide variety of mental health conditions, but only honorably discharged military veterans and people who were previously employed as a first responder would qualify for the program, according to the bill’s text at first reading. Treatments would be administered “under medical supervision and control” by an HHS-approved practitioner.
Meanwhile, the Nevada Senate Committee on Legislative Operations and Elections heard a resolution Tuesday urging Congress to expand research on the therapeutic use of certain psychedelics, NEWS4 reports. The resolution was presented by Sen. Rochelle Nguyen, who joined Assemblymember Carter at the policy summit earlier this year.
“At the end of the day, we need the federal government to take the lead and give guidance to all 50 states. Otherwise, we’re going to end up in a similar situation that we do with cannabis, where you have individual states doing things on an individual level.” — Sen. Nguyen, via NEWS4
Get daily cannabis business news updates. Subscribe
End